We are live on
!
Find out more
B
Bailard Portfolio holdings
AUM
$4.35B
1-Year Est. Return
23.57%
This Fund
S&P 500
This Quarter
Est. Return
+3.12%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$4.52B
AUM Growth
-$85.5M
(-1.9%)
Cap. Flow
-$178M
Cap. Flow
% of AUM
-3.94%
Top 10 Holdings %
Top 10 Hldgs %
31.88%
Holding
897
New
120
Increased
212
Reduced
333
Closed
153
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
|
+$26.9M |
| 2 |
iShares Short-Term National Muni Bond ETF
SUB
|
+$8.23M |
| 3 |
Gilead Sciences
GILD
|
+$7.91M |
| 4 |
JMTG
JPMorgan Mortgage-Backed Securities ETF
JMTG
|
+$7.7M |
| 5 |
iShares US Treasury Bond ETF
GOVT
|
+$7.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$20.5M |
| 2 |
NVIDIA
NVDA
|
+$15.2M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$14.7M |
| 4 |
Meta Platforms (Facebook)
META
|
+$14.2M |
| 5 |
Advanced Micro Devices
AMD
|
+$11.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.36% |
| 2 | Financials | 7.83% |
| 3 | Healthcare | 7.13% |
| 4 | Communication Services | 6.57% |
| 5 | Consumer Discretionary | 4.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Boston Scientific
BSX
$64.8B
| $19.3M | 0.43% |
202,156
-1,291
| -0.6% | -$127K |
|
52
Chubb
CB
$137B
| $18.8M | 0.42% |
60,213
-1,166
| -2% | -$341K |
|
53
Vanguard FTSE Developed Markets ETF
VEA
$226B
| $18.7M | 0.41% |
299,526
+7,801
| +3% | +$478K |
|
54
Eaton
ETN
$161B
| $18.1M | 0.4% |
56,843
-1,901
| -3% | -$674K |
|
55
Waste Management
WM
$95.3B
| $17.5M | 0.39% |
79,667
-3,485
| -4% | -$743K |
|
56
Steel Dynamics
STLD
$34.7B
| $17.3M | 0.38% |
102,031
+865
| +0.9% | +$137K |
|
57
iShares Expanded Tech Sector ETF
IGM
$10.1B
| $16.8M | 0.37% |
130,075
-7,563
| -5% | -$980K |
|
58
ConocoPhillips
COP
$146B
| $16.6M | 0.37% |
177,475
+872
| +0.5% | +$78.9K |
|
59
S&P Global
SPGI
$124B
| $16.6M | 0.37% |
31,748
+376
| +1% | +$186K |
|
60
Vanguard FTSE Emerging Markets ETF
VWO
$119B
| $16.3M | 0.36% |
303,791
-191,642
| -39% | -$10.4M |
|
61
Chevron
CVX
$387B
| $16.3M | 0.36% |
107,005
-7,962
| -7% | -$1.21M |
|
62
Amgen
AMGN
$201B
| $16.2M | 0.36% |
49,565
+1,356
| +3% | +$430K |
|
63
Danaher
DHR
$135B
| $15.9M | 0.35% |
69,384
-713
| -1% | -$157K |
|
64
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.3B
| $15.8M | 0.35% |
294,024
+21,190
| +8% | +$1.15M |
|
65
Vertex Pharmaceuticals
VRTX
$120B
| $15.4M | 0.34% |
33,975
-664
| -2% | -$286K |
|
66
Berkshire Hathaway Class B
BRK.B
$1.06T
| $14.7M | 0.33% |
29,262
-1,334
| -4% | -$664K |
|
67
AstraZeneca
AZN
$261B
| $14.6M | 0.32% |
79,507
+4,801
| +6% | +$842K |
|
68
iShares Core S&P Small-Cap ETF
IJR
$109B
| $14.6M | 0.32% |
121,596
-923
| -0.8% | -$110K |
|
69
iShares MSCI ACWI ex US ETF
ACWX
$11.4B
| $14.3M | 0.32% |
212,394
+5,590
| +3% | +$370K |
|
70
Eli Lilly
LLY
$1.06T
| $13.7M | 0.3% |
12,772
-634
| -5% | -$606K |
|
71
iShares MSCI Emerging Markets ETF
EEM
$28.6B
| $13.5M | 0.3% |
247,528
-197
| -0.1% | -$10.7K |
|
72
Accenture
ACN
$84.9B
| $13.2M | 0.29% |
49,138
-5,283
| -10% | -$1.34M |
|
73
AbbVie
ABBV
$454B
| $12.9M | 0.28% |
56,246
+10,893
| +24% | +$2.48M |
|
74
iShares Russell 2000 Value ETF
IWN
$14.3B
| $12.5M | 0.28% |
69,165
+3,260
| +5% | +$586K |
|
75
Bank of America
BAC
$430B
| $12.5M | 0.28% |
227,456
+276
| +0.1% | +$14.6K |
|
Similar funds
EC
SFM
NHC
EQF
NEI
MYIA
Bailard's Q4 2025 Portfolio in Review
As of Q4 2025, Bailard held 897 positions worth $4.52B, down 1.9% from $4.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Bailard withdrew a net $178M in Q4 2025, closing 153 positions and reducing 333 holdings. Its most notable exit was Vanguard Small-Cap Growth ETF, an estimated $5.29M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Bailard opened a new position in Vanguard Short-Term Inflation-Protected Securities Index Fund worth $26.6M.
- Bailard's largest Q4 2025 buy was Vanguard Short-Term Inflation-Protected Securities Index Fund: 538,707 shares worth $26.6M.
- Bailard added most to iShares Short-Term National Muni Bond ETF in Q4 2025, an estimated $8.23M increase.
- Bailard's biggest Q4 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $20.5M.
- Bailard fully exited Vanguard Small-Cap Growth ETF in Q4 2025, selling an estimated $5.29M.
- Bailard's ten largest holdings make up 32% of its $4.52B portfolio in Q4 2025.
- Bailard opened 120 new positions and closed 153 in Q4 2025.
- Bailard's portfolio value fell 1.9% quarter-over-quarter to $4.52B.
Based on Bailard's 13F filing for Q4 2025, filed 4 Feb 2026.